©The Author(s) 2025.
World J Virol. Dec 25, 2025; 14(4): 113217
Published online Dec 25, 2025. doi: 10.5501/wjv.v14.i4.113217
Published online Dec 25, 2025. doi: 10.5501/wjv.v14.i4.113217
Figure 3 Potential benefits of anticoagulation in hepatitis C virus cirrhosis.
Anticoagulation in patients with hepatitis C virus-related cirrhosis may reduce portal vein thrombosis, limit hepatic decompensation, and improve survival. HCV: Hepatitis C virus; PVT: Portal vein thrombosis.
- Citation: Zohery M, Jahangir S, Jenna HC, Sarfraz S, Ali H, Raza M, Rafiq T, Dahiya DS, Jahagirdar V, Ali H. Thrombotic risk in hepatitis C: Interplay between hepatic dysfunction, viral-driven inflammation, and cardiovascular consequences. World J Virol 2025; 14(4): 113217
- URL: https://www.wjgnet.com/2220-3249/full/v14/i4/113217.htm
- DOI: https://dx.doi.org/10.5501/wjv.v14.i4.113217